D
espite considerable efforts to implement guidelines for prevention of ventilator-associated pneumonia (VAP) (1, 2) , this complication remains common among critically ill patients (3) (4) (5) . VAP increases duration of ventilation (6) , intensive care unit stay and, consequently, costs (4) , and contributes to increased mortality (4) .
Although most if not all VAP are due to bacteria, the role if any of fungal pathogens is unclear in immunocompetent hosts. Indeed, many studies have reported the presence of Candida species in the lungs of immunocompetent, ventilated patients (2, 7, 8) , but it is usually accepted that lung infection is quite rare in these patients (9) , and, thus, there is no specific recommendation for the management of nonimmunocompromised ventilated patients with Candida-positive airway specimens (10) .
Despite these uncertainties, some clinical findings suggest a possible interaction between bacterial pathogens, mainly Pseudomas aeruginosa and Candida species. Indeed, Candida species and P. aeruginosa were among the most common microorganisms retrieved from endotracheal tube biofilm and tracheal secretions in patients with VAP (11) . Even more intriguingly, a recent observational study found a statistical link between airway colonization with Candida species and P. aeruginosa VAP (12) . Obviously, this does not imply causality between the two events, but these findings highlight the importance of clarifying whether Candida airway colonization is a risk factor for P. aeruginosa pneumonia and not a bias reflecting a concealed immunocompromised pulmonary status. The demonstration of a causal link between previous candidal colonization and subsequent infection with P. aeruginosa would open to a new approach in the prevention of VAP. This approach-that would consider eradication of such colonization (an option that has never been tested)-would obviously only be part of the already validated measures of VAP prevention. If proved valuable, such an approach would be worth trying because death rates associated with P. aeruginosa pneumonia are particularly high, ranging from 70% to Ͼ80% (13) (14) (15) . But enthusiasm must be tempered pending the results of well-conducted experimental studies that demonstrate or rule out an actual sequence of events linking fungal colonization with bacterial infection. To our knowledge, such an experimental demonstration has never been performed.
We, therefore, studied the relationship between C. albicans colonization and the occurrence of P. aeruginosa pneumonia in immunocompetent rats.
MATERIALS AND METHODS
Experiments were performed in pathogenfree male Wistar rats weighing 275-300 g in compliance with the recommendations of the French Ministry of Agriculture and approved by the French Veterinary Services.
Microorganisms
A nonmucoid P. aeruginosa wild-type strain was recovered from the peripheral blood of a patient with P. aeruginosa VAP. Fluconazole-susceptible C. albicans was recovered from the bronchoalveolar lavage of a nonimmunocompromised patient also ventilated in our intensive care unit. The strains were stored at Ϫ80°C in Luria-Bertani (LB) media with 10% glycerol.
P. aeruginosa was grown on LB agar for 24 hours, then one colony was picked up and grown overnight in LB broth at 37°C. After two washes with saline, it was diluted to obtain the chosen concentration. C. albicans was plated on Sabouraud agar with chloramphenicol for 48 hours at 37°C. One colony was diluted in saline at the chosen concentration. Ethanol-killed C. albicans were obtained by 30 minutes exposure to 100% ethanol. Ethanol was removed by four successive washes in saline. P. aeruginosa and live C. albicans concentrations were controlled for each experiment.
Microorganisms were inoculated by transglottic instillation (16, 17) under light anesthesia with pentobarbital (Sigma, France) and sevoflurane (Abbott, France). Live or ethanolkilled C. albicans (2 ϫ 10 6 colony-forming units [CFU]) were instilled intratracheally. P. aeruginosa (10 4 CFU) was instilled in a main bronchus. Remaining instillate was cultured to make sure the desired concentration of the appropriate microorganism had been instilled.
Histologic Analysis
The macroscopic aspect of each lung was rated for the presence or absence of an inflammation by two independent observers, unaware of rat group allocation. A macroscopic pulmonary inflammation was defined by the presence of a red or a gray congestion (18) (macroscopic scoring grid above 2 [19] ). Fifteen additional rats were instilled in the trachea with 10 mL 10% formaldehyde. The trachea was tied and the lungs immersed in 10% formaldehyde. Paraffin-embedded sections were stained with hematoxylin-eosin and periodic acid Schiff.
In Vivo Experiments
Part 1: Instillations of Live or EthanolKilled C. albicans Without P. aeruginosa. Rats (n ϭ 18) were instilled on days 1, 2, and 3 with either live (n ϭ 6), ethanol-killed (n ϭ 6) C. albicans, or saline (n ϭ 6). Two additional rats per group enabled histologic analysis.
Part 2: Instillations of Live or EthanolKilled C. albicans With P. aeruginosa. Rats (n ϭ 70) were instilled on day 1, day 2, and day 3 with either live (n ϭ 30), ethanol-killed (n ϭ 10) C. albicans or saline (n ϭ 30). P. aeruginosa instillation was performed on day 2. Three additional rats per group enabled histologic analysis.
Rats were weighed each day and killed on day 4.
Organ Cultures. The right and left lungs were aseptically removed, homogenized, and plated accordingly for culture. Quantitative bacterial counts were obtained by plating serial dilutions on Drigalski agar, LB agar with fluconazole, and Sabouraud agar with chloramphenicol (Biomérieux, France) to confirm that no other microorganism than those instilled grew.
Pneumonia Definition. P. aeruginosa pneumonia was defined as the conjunction of a macroscopic pulmonary inflammation and a lung bacterial count Ͼ10 4 CFU per lung (a normal rat lung weighs Ͻ1 g) (20) .
Cytokines. Lung homogenates were stored at Ϫ80°C before cytokines assays. Tumor necrosis factor-alpha (TNF-␣), interleukin-6, and interferon-gamma (IFN-␥) were assayed in lung homogenates using specific rat enzymelinked immunosorbent assay kits (R&D Systems, France and Biosource Europe, Belgium). Detection threshold were respectively 5, 30, and 13 pg/mL. 4 colony-forming units (CFU) of P. aeruginosa (ordinate: % of cytokine concentrations in rats instilled with P. aeruginosa alone). With P. aeruginosa instillation: cytokine concentrations in lung homogenates of rats instilled with ethanol-killed or live C. albicans before P. aeruginosa instillation compared with rats instilled with saline before P. aeruginosa instillation. TNF-␣, IFN-␥, and interleukin (IL)-6 concentrations were significantly higher in rats instilled with live C. albicans and P. aeruginosa (p Ͻ 0.0001, Kruskal-Wallis test, all p Ͻ 0.05 comparing rats instilled with live C. albicans and P. aeruginosa either with rats instilled with saline and P. aeruginosa or with rats instilled with ethanol-killed C. albicans and P. aeruginosa, NS comparing the two last groups, Dunn's post hoc test). enine dinucleotide phosphate oxidase, which produces superoxide anions and generates other reactive oxygen species (ROS), such as hydrogen peroxide. This macrophage function can be evaluated by luminol-amplified chemiluminescence technique, as previously described (21 
In Vitro Experiments

RESULTS
Part 1: Effect of C. albicans in the Absence of P. aeruginosa Instillation.
Mean rat weight increased in the control group and the groups given live or ethanol-killed C. albicans (5.6 Ϯ 1.4%, 2.3 Ϯ 0.8%, and 2.3 Ϯ 0.2, respectively, not significant [NS], two-way ANOVA). Lung cultures showed 3.0 Ϯ 0.2 ϫ 10 6 CFU of C. albicans when live C. albicans was instilled and no growth in the two other groups. TNF-␣ and IFN-␥ were significantly higher in lung homogenates of rats instilled with live C. albicans compared with those from the two other groups (p Ͻ 0.01, Kruskal-Wallis test) (Fig. 1A ). Interleukin-6 was similar in rats instilled with saline, live or ethanolkilled C. albicans (NS, Kruskal-Wallis test) (Fig. 1A) .
Part 2: Effect of C. albicans With P. aeruginosa Instillation. Two rats died during P. aeruginosa instillation (one in the live C. albicans group, the other in the saline control group). Weight variation over time differed significantly (p Ͻ 0.0001, two-way ANOVA): mean weight of rats instilled with P. aeruginosa decreased by 2.2 Ϯ 0.9% on day 3 in the group given live C. albicans but increased by 1.9 Ϯ 0.3% and 1.0 Ϯ 0.4% in the group instilled with saline and the one instilled with ethanol-killed C. albicans, respectively.
Macroscopic pulmonary inflammation, whatever P. aeruginosa count on lung culture, was significantly more frequent in rats given live C. albicans (23 of 29) than in the rats given saline or ethanol-killed C. albicans (9 of 29 and 6 of 10, respectively, p ϭ 0.001, chi-square test) and was always noticed when bacterial count was Ͼ10 4 CFU per lung. P. aeruginosa pneumonia was significantly more frequent in rats given C. albicans (10 of 29) than saline (1 of 29) (p Ͻ 0.01, Fisher's test) or ethanol-killed C. albicans (0 of 10) (p Ͻ 0.05, Fisher's test). Figure 2 shows P. aeruginosa counts in rats given saline, live or ethanol-killed C. albicans. Quantitative lung cultures for C. albicans were similar whether or not rats developed P. aeruginosa pneumonia (1.4 Ϯ 0.2 ϫ 10 6 and 1.5 Ϯ 0.2 ϫ 10 6 CFU per lung, respectively; NS, Mann-Whitney test) in rats that received live C. albicans instillation. No candidal growth was observed in the two other groups.
Rats given live C. albicans and instilled with P. aeruginosa had higher TNF-␣, IFN-␥, and interleukin-6 pulmonary concentrations than those instilled with saline or ethanol-killed C. albicans and P. aeruginosa (all p Ͻ 0.0001, Kruskal-Wallis test) (Fig. 1B) .
Pathologic Analysis. In the absence of P. aeruginosa (part 1), none of the lungs instilled with saline, live or ethanol-killed C. albicans displayed macroscopic or microscopic aspect of pneumonia. Live but not ethanol-killed C. albicans was responsible for rare spots of peribronchial inflammation (Fig. 3A) . Yeast forms were largely prevalent, but a few pseudohyphae could be disclosed after extensive search (Fig. 3B) . Figure 4A shows a typical aspect of macroscopic pneumonia seen after P. aeruginosa instillation (part 2). A typical histologic aspect of P. aeruginosa pneumonia (widespread alveolitis with infiltration of polymorphonuclear cells [PMN] ) is shown in Figure 4B . C. albicans (be it yeast or pseudohyphae forms) were never observed in these zones of P. aeruginosa pneumonia.
Production of ROS by Alveolar Macrophages. Live C. albicans inhibited luminol-amplified chemiluminescence of alveolar macrophages stimulated with opsonized zymozan (p Ͻ 0.001, KruskalWallis test and p Ͻ 0.001, Dunn's post hoc test). In contrast, ethanol-killed C. albicans was without effect (NS, Dunn's post hoc test) (Fig. 5) .
DISCUSSION
To our knowledge, our prospective randomized animal study constitutes the first demonstration of a phenomenon of facilitation between airway colonization with Candida species and P. aeruginosa pneumonia. These findings might have important clinical relevance. Indeed, given the high frequency of Candida species colonization of the airway of mechanically ventilated patients (2, 7, 8) and the important number of patients who develop P. aeruginosa pneumonia (13) (14) (15) , these experimental results provide a strong rationale for performing clinical studies aimed at implementing the arsenal of VAP prevention through treatment of fungal colonization. If proved valuable, this totally new concept might help reduce the severe toll paid by patients to P. aeruginosa VAP in terms of morbidity and mortality. The most striking observation of this study was that a P. aeruginosa inoculum that does not lead to bacterial pneumonia does so in the presence of C. albicans in the airways. This effect was not observed with ethanol-killed C. albicans. In addition, we found that ROS production by alveolar macrophages was significantly depressed by live but not ethanol-killed C. albicans. Taken together, these results suggest that live C. albicans impairs alveolar macrophage function, which may in turn favor P. aeruginosa pneumonia development.
We aimed to reproduce C. albicans airway colonization by repeated instillations of the fungus. Because rats maintained spontaneous breathing and efficient cough after C. albicans or saline instillation, we repeated instillations to maintain the same level of colonization during the experiments. Only minimal peribronchial inflammation was seen on histologic analysis. Cytokine measurements confirmed the inflammatory process, with an increase in TNF-␣ and IFN-␥ in lung homogenates, in agreement with TNF-␣ production by cell lines exposed to C. albicans yeasts (26) . Because rats instilled with C. albicans alone gained weight in the same way as rats not given the fungus, and because lung C. albicans counts were always below initial inoculum, we believe that this presence of C. albicans was closer to colonization than infection. Indeed, the presence of proinflammatory cytokines and mild peribronchial inflammation is compatible with colonization, that must be seen, as recalled by Casadevall and Pirofski (27) , "as a state of infection that results in a continuum of damage from none to great." Finally, additional rats given C. albicans (data not shown) were studied up to 14 days and evolved uneventfully.
Preliminary experiments found that 10 4 CFU P. aeruginosa was the highest bacterial inoculum not associated with pneumonia development when given alone. In the present study, only 3% (1 of 29) of rats not given C. albicans and instilled with this bacterial inoculum displayed P. aeruginosa pneumonia, thus confirming our preliminary finding. Conversely, when rats were given C. albicans, this small P. aeruginosa inoculum produced pneumonia in 34% of the rats. This P. aeruginosa pneumonia development was accompanied by a significant weight loss, whereas animals without pneumonia gained weight. Consistently, lung concentration of proinflammatory cytokines after P. aeruginosa instillation was higher in the group given the fungus. A certain degree of alveolar-capillary barrier injury was also observed in this group with an increased dry lung weight over body weight ratio (data not shown). There was no evidence of systemic dissemination, bacterial culture of the spleen being negative (data not shown). To ensure the robustness of our findings, experiments were repeated with different strains of C. albicans (ATCC 10231) and P. aeruginosa (ATCC 15692), and identical results were obtained (i.e., a significantly higher prevalence of P. aeruginosa in rats colonized with C. albicans) (data not shown).
Two possibilities were explored to explain these observations. First, an effect of C. albicans on P. aeruginosa responsible for increased pathogenicity of the latter; second, a decreased immunity of the host induced by C. albicans that would favor P. aeruginosa growth.
We could reasonably rule out the first hypothesis. Presence of live C. albicans was found to increase local production of proinflammatory cytokines in our study. These cytokines have, in turn, been shown in some (28) but not all studies (28 -30) to modulate growth and virulence of some bacteria. We studied P. aeruginosa growth in vitro in different media (data not shown) and found-in agreement with these latter studies-no effect of cytokines. C. albicans may have favored P. aeruginosa growth by itself: P. aeruginosa can attach to C. albicans filaments and kill the fungus after dense biofilm formation (31) . We rarely observed C. albicans in a filamentous form (pseudohyphae or hyphae) in rat lungs (Fig. 4B) , making it unlikely that P. aeruginosa growth in vivo was due to effects like those observed by Hogan and Kolter (31) in vitro. We did not measure any increase in P. aeruginosa in vitro growth with live or ethanol-killed C. albicans (data not shown).
Second, we explored the possibility that P. aeruginosa pneumonia was facilitated by a decrease in host immunity. The immune cells implicated in the first defense against C. albicans are macrophages (32) . C. albicans could have modulated innate immune response by impairing lung clearance of P. aeruginosa by alveolar macrophage. Because ROS production is a major component of macrophage's anti-pseudomonas activity (32, 33) , we tested this hypothesis by studying macrophage production of ROS in vitro. We found that alveolar macrophages incubated with live C. albicans had a significantly reduced ROS production compared with controls. This finding is in agreement with C. albicans impairment of PMN production of superoxide anion reported by Hilger and Danley (34) . To further ensure that this effect was specific to C. albicans and not a purely mechanical effect, we repeated experiments using ethanol-killed C. albicans. Results showed that macrophage incubated with ethanol-killed C. albicans produced the same level of ROS as controls, thus indicating that viable C. albicans were necessary to decrease macrophage activity. We acknowledge, however, the fact that the role of alveolar macrophages in innate immunity against P. aeruginosa lung infection is quite controversial. Numerous studies support their importance (35, 36) , whereas others refute it (37) . Nonetheless, we believe that alveolar macrophages are important to recruit PMNs (depletion of alveolar macrophages has been shown to decrease neutrophil chemotaxis to Pseudomonas pulmonary infection) and to ensure some phagocytic activity. We deliberately focused on alveolar macrophages because they are the first line of cell-mediated defenses against C. albicans (32). PMNs obviously also play an important role both against C. albicans and even more so against P. aeruginosa. Further studies are required to investigate the respective role of PMNs and alveolar macrophages during P. aeruginosa infection in the context of C. albicans colonization.
Thus, in vitro results were consistent with in vivo findings. We then postulated that airway colonization with C. albicans impairs alveolar macrophage function, resulting in diminished clearance of P.
aeruginosa. This sequence of events allows development of this latter microorganism that otherwise would have been cleared from the lungs, as observed in animals not given C. albicans. This hypothesis parallels a similar but less acute previously described phenomenon: the alteration of macrophage antibacterial activity after viral infection (38) .
Our study may provide the rationale for clinical studies aimed at evaluating the effect of decreasing C. albicans airway colonization on the rate of VAP caused by P. aeruginosa. Indeed, in a recent study (12) , airway colonization with Candida species was found in 26.6% of patients under mechanical ventilation, C. albicans being the main species. P. aeruginosa VAP was found associated with Candida colonization (odds ratio 2.22, p ϭ 0.049). Further evidence for the potential role of C. albicans colonization on P. aeruginosa VAP is given by the retrospective finding that antifungal therapy was associated with reduced risk for P. aeruginosa VAP in patients with Candida species colonization (39).
CONCLUSION
Our results clearly indicate that presence of C. albicans significantly increases the prevalence of P. aeruginosa pneumonia. Because P. aeruginosa VAP may be fatal in up to 71% cases (13) and associated with the highest risk of VAP recurrence (40), our results provide a rational for investigating the potential for antifungal treatment to decrease P. aeruginosa VAP prevalence. Interestingly, this approach has recently proved its efficacy in an experimental model of neonatal infection caused by coagulase-negative staphylococci and C. albicans (41) .
